We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Genecards® Create Exciting New Link Between Human Genes and Chemical Reagents from Tocris Bioscience

Read time: Less than a minute

Dr Robert Felix, Tocris’ Product Manager said, “The new ability provided by GeneCards to rapidly associate Tocris’ high quality research compounds with genes and proteins highlights the central importance of chemical tools in the study of the biology of our genes. We expect that this capability will be of great benefit to life scientists and will lead to new avenues of research.”

The powerful GeneCards search engine provides users with concise genomic, proteomic, transcriptomic, genetic and functional information on all known and predicted human genes.

Information featured in GeneCards includes orthologies, disease relationships, mutations and SNPs, gene expression patterns, gene function, pathways, protein-protein interactions, related drugs and compounds, and direct links to Tocris’ comprehensive 'Target files'

A recent introduction to the Tocris website, ‘Target Files’ consist of a concise summary of the biological target, together with links to external sources of genetic and pharmacological information. Tocris products with activity at each target are listed here allowing rapid identification of the most relevant research tools.

Dr. David Warshawsky, Chief Executive Officer of Xennex Inc., the commercial partner of GeneCards, added “We are very pleased about our work with Tocris and are delighted that GeneCards users will have gene-specific access to Tocris’ high quality research compounds. I am confident that offering access to Tocris’ products will help many of our users in academia and industry in their efforts in areas such as basic research and drug discovery.”